HortenseFouilland

Collaboratrice

Paris + 33.1.56.59.38.76

Hortense Fouilland intervient dans les domaines du private equity, du venture capital (capital-risque), des fusions acquisitions et du droit boursier. Elle assiste les entreprises à fort potentiel de croissance, cotées ou non, leurs dirigeants, les investisseurs industriels et les acteurs du private equity dans toutes leurs opérations et à tous les stades de leur développement, des start-ups aux multinationales. Elle a également travaillé sur des opérations de LBO mid-cap et large cap.

Expérience

  • Nanobiotix completes $113.3 million IPO on NasdaqJones Day represented Nanobiotix S.A., a French clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, in connection with its $113.3 million initial public offering in the United States and listing on Nasdaq.
  • IntegraGen’s shareholders sell majority interest to OncoDNA in tender offerJones Day advised IntegraGen, a biotechnology company developing molecular markers for central nervous system and metabolic diseases, in connection with the public tender offer of shares by OncoDNA, a private health technology and precision medicine company focused on oncology.
  • Elaia Partners participates in €2 million financing of Honing BiosciencesJones Day represented Elaia Partners in connection with the €2 million financing of Honing Biosciences, a French bio-therapeutics company that develops and improves cell-based therapies.
  • European growth VC investor participates in €12.5 million financing round of AlmaJones Day assisted a European growth VC investor in connection with the €12.5 million financing round of Alma, a French fintech which simplified installment payments for e-commerce and in-store merchants.
  • Pharnext raises €7.7 million in private placementJones Day represented Pharnext SA, a biopharmaceutical company pioneering a new approach to developing innovative drug combinations based on its PLEOTHERAPY artificial intelligence platform harnessing big genomics data and network pharmacology, in connection with its €7.7 million private placement of 1,799,061 of new Ordinary Shares.
  • Tinubu® Square acquires U.S. company eSURETY®Jones Day advised Tinubu® Square in its acquisition of U.S.-based eSURETY®, a cloud-based specialty software provider, enabling carriers, brokers, and MGAs to securely apply, quote, bond, issue, and support every form of surety as well as offering a powerful direct-to-the-consumer experience on any device from any browser, anywhere in the world.
  • Carrefour acquires Potager CityJones Day advised Carrefour Group in its acquisition of Potager City, a French distributor of online subscription-based boxes of extra-fresh and seasonal fruit and vegetables sourced via short distribution channels.
  • Valar Ventures and Alven Capital participate in €104 million Series C financing round of QontoJones Day assisted Valar Ventures and Alven Capital in connection with the €104 million Series C round of financing of Qonto, the neobank for SMEs and freelancers, which included China-based Tencent and DST Global as two new global investors.
  • Alven Capital invests in CardiologsJones Day represented Alven Capital SA in connection with its investment in Cardiologs, a company engaged in the development of an AI-based heart disease diagnostic solution by supporting physicians with unprecedented EKG data analysis and reporting capabilities.
  • Macquarie Infrastructure and Real Assets to divest stakes in Autoroutes Paris-Rhin-RhoneJones Day is advising Macquarie Infrastructure and Real Assets (Europe) Limited in the sale by subsidiaries Macquarie Infrastructure Fund 2, Macquarie Mercer Infrastructure Trust 1, and Macquarie Mercer Infrastructure Trust 2 of remaining stakes in Autoroutes Paris-Rhin-Rhone for an aggregate price of €867 million, subject to timing of completion.
  • Cyrus Capital Partners acquires, in French insolvency proceeding, of French business of Toys R UsJones Day represented Cyrus Capital Partners in connection with the acquisition, in a French insolvency proceeding, of the French business (comprised notably of 44 stores) of Toys R Us.
  • *We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.